NON HODGKIN'S LYMPHOMA REFRACTORY/RELAPSED

Clinical trials for NON HODGKIN'S LYMPHOMA REFRACTORY/RELAPSED explained in plain language.

Never miss a new study

Get alerted when new NON HODGKIN'S LYMPHOMA REFRACTORY/RELAPSED trials appear

Sign up with your email to follow new studies for NON HODGKIN'S LYMPHOMA REFRACTORY/RELAPSED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

Experimental cell therapy trial offers hope for lymphoma patients who have run out of options

Disease control Recruiting now

This early-stage study is testing a new cell therapy called CD19 t-haNK, both alone and combined with other drugs, for adults with non-Hodgkin lymphoma that has come back or stopped responding to standard treatments. The main goal is to check the safety of this new approach and s…

Matched conditions: NON HODGKIN'S LYMPHOMA REFRACTORY/RELAPSED

Phase: PHASE1 • Sponsor: ImmunityBio, Inc. • Aim: Disease control

Last updated Apr 03, 2026 14:43 UTC

NON HODGKIN'S LYMPHOMA REFRACTORY/RELAPSED

Get alerted when new NON HODGKIN'S LYMPHOMA REFRACTORY/RELAPSED trials appear

Experimental cell therapy trial offers hope for lymphoma patients who have run out of options